华纳药厂：2025年度业绩快报公告

Group 1 - The core viewpoint of the article is that Warner Pharmaceuticals announced its financial results for the fiscal year 2025, showing significant growth in both revenue and net profit [2] - The company achieved an operating revenue of 1,515.59 million yuan, representing a year-on-year increase of 7.26% [2] - The net profit attributable to the parent company was 241.47 million yuan, reflecting a substantial year-on-year growth of 46.95% [2]